Showing 1,001–1,025 of 7,717 international scientific journals
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1001 | Clays and Clay Minerals ISSN: 0009-8604 / 1552-8367 | 🇺🇸United States | Q3 | CAS Tier 4 | 2.8 | 0.51Q2 | 78 | 52 | 5% | Springer International Publishing | Profile |
| 1002 | Clinical Endocrinology ISSN: 0300-0664 / 1365-2265 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.978Q2 | 137 | 222 | 3.3% | Wiley-Blackwell Publishing Ltd | Profile |
| 1003 | Cognition Technology & Work ISSN: 1435-5558 / 1435-5566 | 🇬🇧United Kingdom | Q3 | CAS Tier 2 | 2.8 | 0.839Q1 | 29 | 44 | 8.3% | Springer London | Profile |
| 1004 | Cpt-Pharmacometrics & Systems Pharmacology ISSN: 2163-8306 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.8 | 0.948Q1 | — | 143 | 16.1% | WILEY | Profile |
| 1005 | Crystallography Reviews ISSN: 0889-311XTop Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 2.8 | 0.393Q3 | 24 | 5 | 0% | Taylor and Francis Ltd. | Profile |
| 1006 | Current Medical Research and Opinion ISSN: 0300-7995 / 1473-4877 | 🇬🇧United Kingdom | Q1 | CAS Tier 4 | 2.8 | 0.83Q2 | 98 | 230 | 4.2% | Taylor and Francis Ltd. | Profile |
| 1007 | Current Microbiology ISSN: 0343-8651 / 1432-0991 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.8 | 0.634Q2 | 79 | 368 | 0% | Springer US | Profile |
| 1008 | Current Opinion in Allergy and Clinical Immunology ISSN: 1528-4050 / 1473-6322 | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.798Q2 | 76 | 74 | 6.7% | Lippincott Williams and Wilkins Ltd. | Profile |
| 1009 | Current Opinion in Gastroenterology ISSN: 0267-1379 / 1531-7056Top Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.941Q2 | 73 | 85 | 0% | Lippincott Williams and Wilkins Ltd. | Profile |
| 1010 | Daru-Journal of Faculty of Pharmacy ISSN: 1560-8115 / 2008-2231 | 🌐Iran | Q3 | CAS Tier 4 | 2.8 | 0.519Q3 | 33 | 47 | 0% | Springer International Publishing | Profile |
| 1011 | Daru-Journal of Pharmaceutical Sciences ISSN: 2008-2231 | 🌐Iran | Q3 | CAS Tier 4 | 2.8 | — | — | 47 | 0% | Springer International Publishing | Profile |
| 1012 | Discover Oncology ISSN: 2730-6011 | 🇨🇭Switzerland | Q3 | CAS Tier 3 | 2.8 | 0.731Q2 | — | 62 | 0% | Springer Nature | Profile |
| 1013 | Dose-Response ISSN: 1559-3258 | 🇺🇸United States | Q3 | CAS Tier 4 | 2.8 | 0.569Q2 | 30 | 93 | 4.3% | International Dose-Response Society | Profile |
| 1014 | Energy Journal ISSN: 0195-6574 / 1944-9089 | 🇺🇸United States | Q1 | CAS Tier 3 | 2.8 | 0.856Q2 | 68 | 65 | 10.5% | International Association for Energy Economics | Profile |
| 1015 | Environmental Data Science ISSN: 2634-4602 | 🌐International | Q3 | CAS Tier 4 | 2.8 | 0.652Q2 | — | — | N/A | Updating | Profile |
| 1016 | Ergonomics ISSN: 0014-0139 / 1366-5847 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.681Q2 | 97 | 123 | 15% | Taylor and Francis Ltd. | Profile |
| 1017 | Expert Review of Hematology ISSN: 1747-4086 / 1747-4094 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 2.8 | 0.702Q2 | 31 | 93 | 4.3% | Taylor and Francis Ltd. | Profile |
| 1018 | Expert Review of Medical Devices ISSN: 1743-4440Top Tier | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.548Q2 | 55 | 123 | 6.9% | Taylor and Francis Ltd. | Profile |
| 1019 | FinTech ISSN: 2674-1032 | 🌐International | Q2 | — | 2.8 | 0.619Q1 | — | — | N/A | Updating | Profile |
| 1020 | Genes and Nutrition ISSN: 1865-3499 | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.978Q2 | 41 | 19 | 0% | BioMed Central | Profile |
| 1021 | Genesis ISSN: 1526-968X | 🌐International | Q2 | CAS Tier 4 | 2.8 | — | 100 | 1 | 0% | Updating | Profile |
| 1022 | Genesis ISSN: 1526-954X / 1526-968X | 🇺🇸United States | Q2 | CAS Tier 4 | 2.8 | 0.87Q2 | 101 | 37 | 0% | Wiley-Liss Inc. | Profile |
| 1023 | Geoscience Data Journal ISSN: 2049-6060 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 2.8 | 0.787Q1 | 6 | 26 | 9.1% | John Wiley and Sons Inc. | Profile |
| 1024 | Global Health-Science and Practice ISSN: 2169-575XDiamond OA | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.949Q1 Diamond OA | — | 87 | 8% | U.S. Agency for International Development | Profile |
| 1025 | Group Decision and Negotiation ISSN: 0926-2644 / 1572-9907 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.8 | 0.582Q1 | — | 54 | 11.1% | Springer Nature | Profile |